Csenge Advisory Group

SEC CIK: 0001715593
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

SRNE holding history

Sorrento Therapeutics, Inc. in every 13F filed by Csenge Advisory Group, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRNE overview All 13F holders of SRNE Full Q2 2026 holdings

Shares (Q1 2023): 0; Sold out in Q1 2023
Value: $0
% of portfolio: 0.0%
Quarters held: 3; Since Q2 2022

Holdings of SRNE by Csenge Advisory Group, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q1 2023	0	$0	0.0%	−51,456−100.0%	Sold out	Holders
Q4 2022	51,456	$45.6K	<0.1%	00.0%	Unchanged	Holders
Q3 2022	51,456	$81.0K	<0.1%	00.0%	Unchanged	Holders
Q2 2022	51,456	$103.0K	<0.1%	+51,456	New	Holders